Nath Bio-Genes (India) Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
NATHBIOGEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Nath Bio-Genes (India) Limited has informed the exchanges that its trading window will remain closed from Wednesday, 01st April, 2026, until 48 hours after the declaration of audited financial results for the quarter and financial year ended 31st March, 2026. This is being done in line with SEBI's Prohibition of Insider Trading Regulations, 2015 and the company's own insider trading code. The exact date of the board meeting where the audited results will be approved has not been disclosed yet and will be communicated separately. The intimation was signed by Amol Gupta, the Chief Financial Officer of the company, on 26th March 2026.
This is a routine compliance filing and not an operational update, so it is unlikely to have any direct impact on the stock price. Insiders, promoters, directors, and certain employees will not be permitted to buy or sell shares of the company during this blackout period, which is standard practice ahead of annual results. Retail investors should watch for the upcoming audited FY26 results announcement for any meaningful business signals.